Dechra Pharmaceuticals plc (LON:DPH) declared a dividend on Monday, September 3rd, Upcoming.Co.Uk reports. Shareholders of record on Thursday, October 25th will be given a dividend of GBX 18.17 ($0.24) per share on Friday, November 16th. This represents a yield of 0.74%. The ex-dividend date is Thursday, October 25th. This is an increase from Dechra Pharmaceuticals’s previous dividend of $7.33. The official announcement can be viewed at this link.
LON DPH opened at GBX 2,332 ($30.47) on Friday. Dechra Pharmaceuticals has a 1-year low of GBX 1,622 ($21.19) and a 1-year high of GBX 2,720 ($35.54).
Separately, Numis Securities lifted their target price on Dechra Pharmaceuticals from GBX 2,640 ($34.50) to GBX 2,950 ($38.55) and gave the company an “add” rating in a research report on Tuesday, July 10th.
Dechra Pharmaceuticals PLC develops, manufactures, regulates, markets, and sells veterinary pharmaceuticals and related products for veterinarians worldwide. It operates through European Pharmaceuticals, North American Pharmaceuticals, and Pharmaceuticals Research and Development segments. The company offers various endocrinology, dermatology, analgesia and anesthesia, cardiovascular, and critical care products for dogs and cats; water soluble antibiotics, poultry vaccines, and locomotion and pain management products for poultry, pigs, and cattle; and lameness and pain management products for horses and ponies.
Further Reading: What is the Dow Jones Industrial Average (DJIA)?
Receive News & Ratings for Dechra Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dechra Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.